Follow the Newron Pharmaceuticals S.p.A. share price and the full directors' dealings record of the company, a publicly traded company based in Switzerland. Shares are listed on the CH market, under the oversight of SIX SER. Operating in the Health Care sector, Newron Pharmaceuticals S.p.A. has published 13 insider filings. Market capitalisation: €269.6m. The latest transaction was reported on 12 August 2026 (Purchase). All data is free.
13
Insider Decl.
n/a
Thresholds
€266,768
10 ops.
Buy Volume
€487,256
3 ops.
Sell Volume
24Σ signal
Buys €266,768€487,256 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 12 August 2026
Declarations13 total
●
Anonymous (an executive member of the board of directors / member of senior management)
an executive member of the board of directors / member of senior management·Executives·(filed)
10,382 shares@ CHF 10.467818.5% of flowISINISIN IT0004147952SIX:T1O5G000E3
13 of 13 declarations
About Newron Pharmaceuticals S.p.A.
Newron Pharmaceuticals S.p.A. is a biopharmaceutical company focused on developing treatments for central nervous system diseases. It is listed on the Swiss Stock Exchange (XSWX).